Gilead sciences announces statistically significant antiviral activity against hepatitis B virus.
D000998:Antiviral Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006509:Hepatitis B / Q000188:drug therapy*; D006801:Humans; D015337:Multicenter Studies as Topic; D019562:Viral Load
D000998:Antiviral Agents